News items related to:
-
Fundación GEP Marks Landmark Wins on Lenacapavir and Cabotegravir for Affordable HIV Prevention and Treatment in Argentina
The filing of oppositions is a fundamental strategic line of the FGEP’s Health Access Program, which allows the prevention and...
-
No Borders, No Barriers: Communities Call for Universal Access to Lenacapavir
Lenacapavir – a twice-yearly HIV prevention injection – could transform the fight against HIV. But Gilead’s restrictive voluntary license excludes...
-
Activists Demand $40-a-year Generic Price for Breakthrough HIV Prevention Drug be Made Available to all Low- and Middle-Income Countries
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP...
-
UN High-Level Meeting on NCDs: Declaration Without Affordability Is Just Empty Words
Weaknesses in the Draft Declaration Civil society groups warn that the latest draft does not reference the right of governments...